Cargando…

Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers

Despite the substantial changes resulting from the introduction of combination antiretroviral therapy (cART), the prevalence of HIV-associated neurocognitive disorders (HAND) remains substantial. Blood–brain barrier impairment (BBBi) is a frequent feature in people living with HIV (PLWH) and it may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caligaris, Giulia, Trunfio, Mattia, Ghisetti, Valeria, Cusato, Jessica, Nigra, Marco, Atzori, Cristiana, Imperiale, Daniele, Bonora, Stefano, Di Perri, Giovanni, Calcagno, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151579/ https://www.ncbi.nlm.nih.gov/pubmed/34065785 http://dx.doi.org/10.3390/diagnostics11050867

Ejemplares similares

Patterns of Cerebrospinal Fluid Alzheimer’s Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition
por: Trunfio, Mattia, et al.
Publicado: (2022)

Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Stroffolini, Giacomo, et al.
Publicado: (2021)

Co-infection with other respiratory pathogens in COVID-19 patients
por: Calcagno, Andrea, et al.
Publicado: (2021)

Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare Workers
por: Trunfio, Mattia, et al.
Publicado: (2021)

Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy
por: Calcagno, Andrea, et al.
Publicado: (2021)

On the SARS-CoV-2 “Variolation Hypothesis”: No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases
por: Trunfio, Mattia, et al.
Publicado: (2021)

Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases
por: Trunfio, Mattia, et al.
Publicado: (2021)

Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study
por: Cusato, Jessica, et al.
Publicado: (2022)

Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases
por: Trunfio, Mattia, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL
por: Calcagno, Andrea, et al.
Publicado: (2014)

Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants
por: Cusato, Jessica, et al.
Publicado: (2023)

Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients
por: Trunfio, Mattia, et al.
Publicado: (2021)

Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options
por: Trunfio, Mattia, et al.
Publicado: (2022)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)

The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries
por: Trunfio, Mattia, et al.
Publicado: (2021)

A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load
por: Calcagno, A, et al.
Publicado: (2010)

Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV
por: De Nicolò, Amedeo, et al.
Publicado: (2020)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what matters
por: Cosma, Stefano, et al.
Publicado: (2021)

Analytical Validation and Clinical Application of Rapid Serological Tests for SARS-CoV-2 Suitable for Large-Scale Screening
por: De Nicolò, Amedeo, et al.
Publicado: (2021)

Living with HIV and Getting Vaccinated: A Narrative Review
por: De Vito, Andrea, et al.
Publicado: (2023)

Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients
por: Cosma, Stefano, et al.
Publicado: (2021)

Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery
por: Cosma, Stefano, et al.
Publicado: (2021)

Obstetric and neonatal outcomes after SARS‐CoV‐2 infection in the first trimester of pregnancy: A prospective comparative study
por: Cosma, Stefano, et al.
Publicado: (2021)

Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz
por: Cusato, Jessica, et al.
Publicado: (2021)

Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma
por: De Nicolò, Amedeo, et al.
Publicado: (2021)

COVID-19: A Possible Contribution of the MAPK Pathway
por: Cusato, Jessica, et al.
Publicado: (2023)

COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics
por: Cusato, Jessica, et al.
Publicado: (2023)

Prenatal Biochemical and Ultrasound Markers in COVID-19 Pregnant Patients: A Prospective Case-Control Study
por: Cosma, Stefano, et al.
Publicado: (2021)

Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it?
por: Carosso, Andrea, et al.
Publicado: (2020)

Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring
por: Cusato, Jessica, et al.
Publicado: (2021)

Louseborne Relapsing Fever among East African Refugees, Italy, 2015
por: Lucchini, Anna, et al.
Publicado: (2016)

Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy
por: MASTORINO, Luca, et al.
Publicado: (2022)

Monthly Increase in Vitamin D Levels upon Supplementation with 2000 IU/Day in Healthy Volunteers: Result from “Integriamoci”, a Pilot Pharmacokinetic Study
por: Avataneo, Valeria, et al.
Publicado: (2022)

Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections
por: Stroffolini, Giacomo, et al.
Publicado: (2022)

A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection
por: Ruggiero, Tina, et al.
Publicado: (2013)

Good times, bad times: A diary of a physician in the COVID-19 era
por: Lupia, Tommaso, et al.
Publicado: (2020)

Viro-Immunological, Clinical Outcomes and Costs of Switching to BIC/TAF/FTC in a Cohort of People Living with HIV: A 48-Week Prospective Analysis
por: Mazzitelli, Maria, et al.
Publicado: (2022)

Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV
por: Mazzitelli, Maria, et al.
Publicado: (2023)

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants
por: Cusato, Jessica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6rriggd3ene13s6afv5gjoj78q